| Structure |
Chemical Name |
CAS |
MF |
![10-[3-(ジメチルアミノ)プロピル]-10H-フェノチアジン5-オキシド](/CAS/GIF/146-21-4.gif) |
10-[3-(ジメチルアミノ)プロピル]-10H-フェノチアジン5-オキシド |
146-21-4 |
C17H20N2OS |
 |
(6E,10E)-7,11,15-トリメチル-3-メチレン-1,6,10,14-ヘキサデカテトラエン |
70901-63-2 |
C20H32 |
 |
CLARITHROMYCIN OXIME |
127253-06-9 |
C38H70N2O13 |
 |
3,5-ジ(ブロモメチル)ピリジン |
35991-75-4 |
C7H7Br2N |
![alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride](/CAS/GIF/63516-30-3.gif) |
alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride |
63516-30-3 |
C21H24ClNO3 |
![N-[4-(メチルアミノ)ベンゾイル]-L-グルタミン酸](/CAS/GIF/52980-68-4.gif) |
N-[4-(メチルアミノ)ベンゾイル]-L-グルタミン酸 |
52980-68-4 |
C13H16N2O5 |
 |
(2R)-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE |
27262-43-7 |
C14H20N2O |
 |
Aids004544 |
145397-25-7 |
C8H10FN3O4 |
 |
1,3-ビス(9H-カルバゾール-4-イルオキシ)-2-プロパノール(CARVEDILOL IMPURITY) |
1276477-91-8 |
C27H22N2O3 |
 |
2-Carboxybenzoyl Amlodipine |
318465-73-5 |
C28H29ClN2O8 |
 |
rac-trans-4-Desfluoro-4-methoxy Paroxetine Hydrochloride |
127017-74-7 |
C20H24ClNO4 |
![[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール](/CAS/GIF/62572-93-4.gif) |
[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール |
62572-93-4 |
C13H21NO3 |
 |
Desmethoxy Fluvoxamine |
1217216-82-4 |
C14H19F3N2O |
 |
4'-Deoxy Vincristine |
68135-16-0 |
C46H56N4O9 |
 |
Demethyl Chlorpromazine Hydrochloride |
3953-65-9 |
C16H18Cl2N2S |
 |
1-シクロプロピル-4-オキソ-6-ヒドロキシ-7-ピペラジノ-1,4-ジヒドロキノリン-3-カルボン酸 |
226903-07-7 |
C17H19N3O4 |
 |
N-(2-Succinyl) Fluvoxamine |
259526-43-7 |
C19H25F3N2O6 |
 |
Methylene-Bis Paroxetine Dihydrochloride |
606968-05-2 |
C39H40F2N2O6 |
 |
Nicorandil N-Oxide |
107833-98-7 |
C8H9N3O5 |
![2-Phenyl-1-[4-(trifluoromethyl)phenyl]ethane 2-(Aminoethyl)oxime (Fluvoxamine Impurity)](/CAS/GIF/1217241-15-0.gif) |
2-Phenyl-1-[4-(trifluoromethyl)phenyl]ethane 2-(Aminoethyl)oxime (Fluvoxamine Impurity) |
1217241-15-0 |
C17H17F3N2O |
 |
CIS-モンテルカスト |
774538-96-4 |
C35H36ClNO3S |
 |
(S)-(-)-トルバプタン |
331947-44-5 |
C26H25ClN2O3 |
 |
N-tert-Butoxycarbonyl Mirabegron |
1329485-55-3 |
C26H32N4O4S |
 |
Phosphine oxide, tris (2-methylphenyl)- |
6163-63-9 |
C21H21OP |
![1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)-](/CAS/GIF/847445-81-2.gif) |
1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)- |
847445-81-2 |
C16H13F6N5O |
 |
4-Difluoromethoxy-2-nitro-aniline |
97963-76-3 |
C7H6F2N2O3 |
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/171596-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
171596-44-4 |
C20H18N2O4 |
 |
アムロジピン-D4 |
1185246-14-3 |
C20H25ClN2O5 |
 |
rac Des(isopropylaMino) Acebutolol Diol |
96480-91-0 |
C15H21NO5 |
 |
(17α)-17-Hydroxy-3-oxo-19-norpregna-5(10),9(11)-diene-21-nitrile |
106111-42-6 |
C20H25NO2 |
![(3S)-N-[[(1S)-1,2,3,4-テトラヒドロ-1-ナフタレニル]メチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン](/CAS/GIF/177793-80-5.gif) |
(3S)-N-[[(1S)-1,2,3,4-テトラヒドロ-1-ナフタレニル]メチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン |
177793-80-5 |
C18H26N2 |
 |
4-(4-フルオロフェニル)-1-メチル-1,2,3,6-テトラヒドロピリジン塩酸塩 |
1012886-75-7 |
C12H15ClFN |
 |
5'(S)-Hydroxy SiMvastatin DISCONTINUED |
149949-05-3 |
C25H38O6 |
 |
5'-Epi-LaMivudine |
136846-20-3 |
C8H11N3O3S |
 |
SiMvastatin 4'-Methyl Ether |
864357-88-0 |
C26H40O5 |
 |
((2S,3S,5S)-3-ヒドロキシ-1,6-ジフェニルヘキサン-2,5-ジイル)ジカルバミン酸TERT-ブチル(チアゾール-5-イルメチル) |
162849-95-8 |
C28H35N3O5S |
 |
4-DesMethoxy-4-broMo TriMethopriM |
16285-82-8 |
C13H15BrN4O2 |
![Diaquo[(1R,2R)-1,2-cyclohexanediaMine]platinuM DiMer Dinitrate](/CAS/GIF/82398-34-3.gif) |
Diaquo[(1R,2R)-1,2-cyclohexanediaMine]platinuM DiMer Dinitrate |
82398-34-3 |
C12H24N5O5Pt2+ |
 |
3-(1-ナフタレニルオキシ)プロピオフェノン |
41198-42-9 |
C19H16O2 |
 |
2-(1,3,2-Dioxaborinan-2-yl)benzamide |
2377611-18-0 |
C10H12BNO3 |
 |
PREDNICARBATE RELATED COMPOUND C (プレドニゾロン-21-プロピオン酸) |
5740-62-5 |
C24H32O6 |
 |
2-(3-ヒドロキシフェニル)-4-メチルチアゾール-5-カルボン酸エチル |
209538-87-4 |
C13H13NO3S |
 |
Pyridine, 3-Methoxy-2-Methyl-4-nitro-, 1-oxide |
15931-25-6 |
C7H8N2O4 |
![1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-](/CAS/GIF/161771-76-2.gif) |
1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro- |
161771-76-2 |
C9H10N2O3S |
 |
(Z)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate |
881995-70-6 |
C11H10F3NO2 |
![(2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2phenylethoxy) carbonyl]propyl]aMino]propanoyl]pyrrolidine-2-carboxylic acid](/CAS/20130318/GIF/CB52605019.gif) |
(2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2phenylethoxy) carbonyl]propyl]aMino]propanoyl]pyrrolidine-2-carboxylic acid |
|
C26H31N2O5 |
 |
Methoxyvinpocetine |
|
|
 |
Butanoic acid, 4-chloro-3-hydroxy-, (3S)- |
106941-19-9 |
C4H7ClO3 |
|
|
EMtricitabine iMpurity D |
|
|
|
|
IMp. D (EP) as SodiuM Salt |
|
|
|
|
RocuroniuMbroMide iMpurity G |
|
|
![5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone](/CAS/20180808/GIF/72744-67-3.gif) |
5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone |
72744-67-3 |
C8H10N2O2S2 |
 |
(1S,2S,3R,4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylate |
229614-51-1 |
C16H30N4O4 |
 |
Bis(4-fluorobenzyl)aMine, 97% |
134227-41-1 |
C14H13F2N |
 |
L-ロイシン酸アシクロビル |
142963-69-7 |
C14H23ClN6O4 |
![8-Chloro-6,11-dihydro-11-(1,2,3,6-tetrahydro-4-pyridinyl-5H-benzo[5,6]cyclohepta[1,2-b]pyridine Monohydrochloride](/CAS/GIF/432543-89-0.gif) |
8-Chloro-6,11-dihydro-11-(1,2,3,6-tetrahydro-4-pyridinyl-5H-benzo[5,6]cyclohepta[1,2-b]pyridine Monohydrochloride |
432543-89-0 |
C19H20Cl2N2 |
![1-[(2'-Cyano[1,1'-biphenyl]-4-yl)MethylaMino]-N-pentanoylcyclopentanecarboxaMide](/CAS/GIF/141745-71-3.gif) |
1-[(2'-Cyano[1,1'-biphenyl]-4-yl)MethylaMino]-N-pentanoylcyclopentanecarboxaMide |
141745-71-3 |
C25H29N3O2 |
 |
PF 2825 |
153012-65-8 |
C21H28N2O5S |
![3,3'-[Dithiobis[(2S,4S)-4,2-pyrrolidinediylcarbonyliMino]]bisbenzoic Acid Dihydrochloride](/CAS/GIF/444057-64-1.gif) |
3,3'-[Dithiobis[(2S,4S)-4,2-pyrrolidinediylcarbonyliMino]]bisbenzoic Acid Dihydrochloride |
444057-64-1 |
C24H27ClN4O6S2 |
 |
エルタペネム二量体型D不純物 |
1199797-41-5 |
C44H50N6O14S2 |
 |
S 00218 |
92700-82-8 |
C15H22N2O4 |
 |
Loratadine IMpurity D |
|
C22H23ClN2O2 |
 |
PeMetrexed EP IMpurity A |
869791-42-4 |
C21H23N5O6 |
|
|
Itraconazole EP IMpurity G |
|
|
 |
(1R,2S)-2-(3,4-ジフルオロフェニル)シクロプロパンアミン塩酸塩 |
1402222-66-5 |
C9H10ClF2N |
 |
IMp. E (EP): 1,4-Bis(diphenylMethyl)piperazine |
216581-01-0 |
C30H30N2 |
 |
21-デヒドロ-6α-メチルプレドニソロン |
58636-50-3 |
C22H28O5 |
 |
α-Hydroxy Flurbiprofen |
61466-95-3 |
C15H13FO3 |
 |
9-AcridinaMine, 6-chloro-2-ethoxy- |
855939-48-9 |
C15H13ClN2O |
![1-(6-メチルピリジン-3-イル)-2-[4-(メチルチオ)フェニル]エタノン](/CAS/20150408/GIF/221615-72-1.gif) |
1-(6-メチルピリジン-3-イル)-2-[4-(メチルチオ)フェニル]エタノン |
221615-72-1 |
C15H15NOS |
 |
Edaravone |
68195-63-1 |
C30H26N6O3 |
 |
Erlotinib IMpurity C |
1312937-41-9 |
C15H20N2O5 |
![(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン](/CAS/20150408/GIF/1229224-93-4.gif) |
(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン |
1229224-93-4 |
C22H26F3N |
 |
SalMeterol iMpurity |
144391-74-2 |
C25H37NO4 |
|
|
ceftazidiMe iMpurity E |
|
|
 |
セフロキシムアキセチル不純物C (85%) |
76598-06-6 |
C18H15Cl3N4O9S |
|
|
Rupatadine iMpurity D |
|
|
![2-(1-[(2-フルオロフェニル)メチル]-1H-ピラゾロ[3,4-B]ピリジン-3-イル)ピリミジン-4,5,6-トリアミン](/CAS/20150408/GIF/428854-24-4.gif) |
2-(1-[(2-フルオロフェニル)メチル]-1H-ピラゾロ[3,4-B]ピリジン-3-イル)ピリミジン-4,5,6-トリアミン |
428854-24-4 |
C17H15FN8 |
![3α-[7-[[(1R)-2α-(3,4-ジフルオロフェニル)シクロプロパン-1β-イル]アミノ]-5-(プロピルチオ)-3H-1,2,3-トリアゾロ[4,5-d]ピリミジン-3-イル]シクロペンタン-1β,2β,5α-トリオール](/CAS/GIF/220347-05-7.gif) |
3α-[7-[[(1R)-2α-(3,4-ジフルオロフェニル)シクロプロパン-1β-イル]アミノ]-5-(プロピルチオ)-3H-1,2,3-トリアゾロ[4,5-d]ピリミジン-3-イル]シクロペンタン-1β,2β,5α-トリオール |
220347-05-7 |
C21H24F2N6O3S |
 |
Doxazosin iMpurity |
1219803-95-8 |
C23H26ClN5O5 |
|
|
Montelukast iMpurity |
2734125-88-1 |
|
 |
Vildagliptin iMpurity A-F |
1846606-32-3 |
C7H10N2O3 |
|
|
AMpicillin EP IMpurity E |
|
|
|
|
Ceftriaxone IMpurit B |
|
|
|
|
Flucloxacillin IMpurity F |
|
|
 |
IMidafenacin IMpurity (1-(3-Cyano-3,3-Diphenylpropyl)-2-Methyl-1H-IMidazoliuM Phosphate) |
562091-56-9 |
C20H22N3O4P |
 |
Lercanidipine IMpurity B |
1119226-97-9 |
C35 H37 N3 O6 |
 |
Milrinone IMpurity 2 |
400063-10-7 |
C12H7N3O2 |
 |
Moxifloxacin Decarboxy Analog |
1322062-57-6 |
C20H24FN3O2 |
 |
Naratriptan IMpurity E |
1346746-73-3 |
C20H32N4O4S2 |
 |
PraMipexole DiMer IMpurity II |
2206826-82-4 |
C20H32N6S2 |
 |
Rosuvastatin Substituted Hydroxy Pentenoic Acid |
910867-11-7 |
C20H24FN3O5S |
 |
EthanediaMide iMpurity k |
2803419-58-9 |
C2H4N2O2 |
![(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/1445580-43-7.gif) |
(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
1445580-43-7 |
C14H21N5O5S |
 |
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxyMethyl)-1-(1H-1,2,4-triazol-1-yl)- |
160709-02-4 |
C14H15F2N3O2 |
 |
Bivalirudin iMpurity |
72378-50-8 |
C6H8N2O4 |
 |
2-(4-TERT-ブチル-3-ヒドロキシ-2,6-ジメチルフェニル)酢酸 |
55699-12-2 |
C14H20O3 |
 |
(S)-Fesoterodine FuMarate |
1431511-18-0 |
C30H41NO7 |
![(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (Levofloxacin IMpurity)](/CAS/20150408/GIF/106939-30-4.gif) |
(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (Levofloxacin IMpurity) |
106939-30-4 |
C19H22FN3O4 |
![(6S,12BR)-6-(1,3-ベンゾジオキソール-5-イル)-2,3,7,12B-テトラヒドロ-2-メチルピラジノ[1',2':1,5]ピロロ[3,4-B]キノリン-1,4,12(6H)-トリオン](/CAS/GIF/531500-48-8.gif) |
(6S,12BR)-6-(1,3-ベンゾジオキソール-5-イル)-2,3,7,12B-テトラヒドロ-2-メチルピラジノ[1',2':1,5]ピロロ[3,4-B]キノリン-1,4,12(6H)-トリオン |
531500-48-8 |
C22H17N3O5 |